Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1573-2568
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France ; volume:61 ; number:10 ; day:28 ; month:1 ; year:2016 ; pages:3072-3083 ; date:10.2016
Digestive diseases and sciences ; 61, Heft 10 (28.1.2016), 3072-3083, 10.2016

Creator
Marcellin, Patrick
Contributor
Zoulim, Fabien
Hézode, Christophe
Causse, Xavier
Roche, Bruno
Truchi, Régine
Pauwels, Arnaud
Ouzan, Denis
Dumortier, Jérôme
Pageaux, Georges-Philippe
Bourlière, Marc
Riachi, Ghassan
Zarski, Jean-Pierre
Cadranel, Jean-François
Tilliet, Valérie
Stern, Christiane
Pétour, Pascal
Libert, Olivier
Consoli, Silla M.
Larrey, Dominique
SpringerLink (Online service)

DOI
10.1007/s10620-015-4027-8
URN
urn:nbn:de:1111-201610133795
Rights
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:58 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Marcellin, Patrick
  • Zoulim, Fabien
  • Hézode, Christophe
  • Causse, Xavier
  • Roche, Bruno
  • Truchi, Régine
  • Pauwels, Arnaud
  • Ouzan, Denis
  • Dumortier, Jérôme
  • Pageaux, Georges-Philippe
  • Bourlière, Marc
  • Riachi, Ghassan
  • Zarski, Jean-Pierre
  • Cadranel, Jean-François
  • Tilliet, Valérie
  • Stern, Christiane
  • Pétour, Pascal
  • Libert, Olivier
  • Consoli, Silla M.
  • Larrey, Dominique
  • SpringerLink (Online service)

Other Objects (12)

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B

Real-World Single-Center Comparison of the Safety and Efficacy of Entecavir, Tenofovir Disoproxil Fumarate, and Tenofovir Alafenamide in Patients with Chronic Hepatitis B

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate

Comparison of lipid profile alterations in chronic hepatitis b patients receiving tenofovir alafenamide or tenofovir disoproxil fumarate

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

Clinical Results of Tenofovir Disoproxil Fumarate in a Hemodialysis Patient with Chronic Hepatitis B

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis

Renal and bone side effects of long-term use of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide fumarate in patients with Hepatitis B: a network meta-analysis

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

Effects of tenofovir alafenamide fumarate on serum lipid profiles in patients with chronic hepatitis B

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis

Chiral Analysis of the Key Intermediates of Tenofovir Alafenamide Fumarate

Chiral Analysis of the Key Intermediates of Tenofovir Alafenamide Fumarate

Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Renal function in Japanese HIV-1-positive patients who switch to tenofovir alafenamide fumarate after long-term tenofovir disoproxil fumarate: a single-center observational study

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization

Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living with HIV: Lipid Changes and Statin Underutilization

Related objects